There’s a new blood test coming your way soon called Galleri. It has the ability to detect more than 50 types of cancer and WHERE the cancer is growing from a single blood draw. It’s going to revolutionize cancer screenings. It was researched and produced from a company called GRAIL. They have performed successful clinical trials and formed partnerships with Amgen, AstraZeneca, and Bristol Myers Squibb. In 2014 Illumina began doing DNA sequencing studies and suspected certain markers may be cancer-identifying, so they formed the spin-off company, GRAIL. Now GRAIL’s technology has been reacquired by Illumina for $8 Billion. Holy GRAIL!!
What this means for us is that the UK will have some immediate plans for cancer screenings via the NHS (UK National Health Services). Then Galleri will be coming to the US via Providence clinics (50 hospitals & 1100 health clinics serving over 5 million patients in California, Washington, and Oregon).
Blood tests have come a LONG way, and I believe this is only the beginning of how genetics are going to change cancer screenings and care. It’s a very exciting time we are living in! See your holistic practitioner for more information of this type of screening.
